CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
63 hedge funds and large institutions have $62.8M invested in Cascadian Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
Holders
63
Holding in Top 10
1
Calls
$4.04M
Puts
$874K
Top Buyers
| 1 | +$7.96M | |
| 2 | +$2.02M | |
| 3 | +$1.61M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.36M |
| 5 |
PC
PointState Capital
New York
|
+$1.03M |
Top Sellers
| 1 | -$4.16M | |
| 2 | -$3.52M | |
| 3 | -$965K | |
| 4 |
Morgan Stanley
New York
|
-$529K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$504K |